University of Vermont

UVM ScholarWorks
Family Medicine Clerkship Student Projects

Family Medicine Community

2015

Implications of Long-term Proton Pump Inhibitor Use: Promoting
Step-Down Therapy for Management of Gastro-esophageal Reflux
Disease in the Outpatient Setting
Sonam Kapadia
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/fmclerk
Part of the Medical Education Commons, and the Primary Care Commons

Recommended Citation
Kapadia, Sonam, "Implications of Long-term Proton Pump Inhibitor Use: Promoting Step-Down Therapy
for Management of Gastro-esophageal Reflux Disease in the Outpatient Setting" (2015). Family Medicine
Clerkship Student Projects. 58.
https://scholarworks.uvm.edu/fmclerk/58

This Book is brought to you for free and open access by the Family Medicine Community at UVM ScholarWorks. It
has been accepted for inclusion in Family Medicine Clerkship Student Projects by an authorized administrator of
UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

Implications of Long-term
Proton Pump Inhibitor Use:
Promoting Step-Down Therapy
for Management of Gastroesophageal Reflux Disease in
the Outpatient Setting
Sonam Kapadia, MS 3

Preceptor: Dr. Robin Pritham
EMMC Family Medicine Clinic, Dec 2014-Jan 2015

Long-term PPI Use & Step-Down Therapy
 GERD – most common GI disease, 20% Western
population, transient LES relaxation

 Classic signs - heartburn, regurgitation
 Lower quality of life than angina, CHF, DM
 ABIM Foundation “Choosing Wisely” initiative for
titrating PPI use to lowest effective dose
 Empiric 4-8 week PPI or H2RA therapy
 PPI top 5 most prescribed medications in North
America

Public Health Implications
 PPIs account for 4.7% hip fractures
 Increased susceptibility to community acquired
pneumonia (CAP) and health-care acquired
pneumonia (HCAP)
 Clostridium difficile colitis

 Malabsorption of magnesium, iron, vitamin B12
 Hypergastrinemia rebound acidity
 Drug-drug and antiplatelet interactions

Bangor Community Perspectives
 Per interview with [Name Withheld], PharmD Associate Professor of Pharmacy
Practice, School of Pharmacy at Husson University, Bangor, ME:
- PPI continuation after hospitalization due to PCP reluctance to discontinue
medications prescribed by gastrointestinal specialists
- “Exceedingly rare to see a de-escalation of PPI therapy as it is rarely observed”
- Confounding variables of adverse effects seen in observational studies
 Per interview with [Name Withheld], MD, Family Medicine Resident:
- 3 months PPI or H2RA response prior to step-down attempt

 Per interview with S.G. 53 year old male patient presenting for follow up on GERD:
- Well controlled symptoms, never offered step-down

Intervention/Methodology

 Chart review of the EMMC Family
Medicine Center Centricity Outpatient
Electronic Medical Records
 Search criteria: Active patients + active
PPI use on medication list + date of last
office visit on or after 7/1/2014
 527 patients met criteria
 Reviewed 50 patient charts

Results
 28% of patients demonstrated improved
GERD/acid reflux symptoms during the
most recent office visit – missed
opportunities for step-down as only 1
patient received intervention
 70% of patients were not asked about their
GERD/acid reflux symptoms over the
course of the last 3 office visits
 14% patients did not have an appropriate
indication for PPI use on problem list
 28% patients had any history of step-down

Effectiveness vs. Limitations

 Small sample size, n=50 of 527 eligible patients
 Acute office visits
 GERD assessment without documentation in assessment & problem of
office visit note
 Patient non-adherence to PPI or inappropriate dosing prior to meals

Future Directions
 Role of computerized clinical decision support prompt in pharmacydispensing software to promote PPI step-down
 Efficacy of antisecretory therapies and optimal use of medications in specific
settings
 Role of diagnostic testing including endoscopy, esophageal manometry,
ambulatory pH monitoring in evaluation of patients with GERD

 Management approaches to atypical GERD patients including patients with
reflux chest pain and extraesophageal reflux syndromes such as asthma,
laryngitis, cough
 Potential adverse effects warranting work up with bone density studies,
calcium supplementation
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Patient Information Slides
Long-term use of PPIs may increase the risk of hip fractures, pneumonia,
vitamin B12 deficiency, and cause drug-drug interactions
Immediate discontinuation of PPIs can cause the stomach to produce
more acid and worsen heartburn symptoms
Ask your physician if you are on the lowest effective dose or if you are
eligible for step-down to reduce your PPI dose or transition to a H2
receptor antagonist

Long term PPI indications – severe esophagitis, strictures, Barrett’s
esophagus, Zollinger Ellison syndrome, use of medications that increase
peptic ulcer risk

Patient Information Lifestyle Modifications
Weight loss
Elevate head of bed 4-8 inches

Avoid acidic, spicy, high fat foods
Avoid alcohol, caffeine, chocolate, onions, garlic, peppermint,
Avoid lying flat 2-3 hours after eating

Avoid tight clothing around waist
Reduce/quit smoking
Moderation of alcohol use

